About us
NovoBind is an integrated animal health company utilizing next-generation biologics to target and neutralize key pathogens affecting producers and food safety. We target pathogens that cause >$1B of production losses and have been materially affected by the following: 1) Antibacterial resistance, 2) A Regulatory ban on antibiotics, and; 3) Changing consumer sentiment.
- Website
-
https://www.novobind.com/
External link for NovoBind
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Vancouver , British Columbia
- Type
- Privately Held
Locations
-
Primary
Get directions
1021 West Hastings MNP tower, 9th floor
Vancouver , British Columbia V6E 2E9, CA
Employees at NovoBind
-
Laurent Genet
DVM, President @ 1722 Consulting | Strategy, Food & Agriculture | Ex-Nutreco | Retired
-
Hamlet Hovanessian Abnousi, CPA CA
Co-Founder and CEO at NovoBind
-
Leticia Torres, PhD
Freelance medical writer specializing in the microbiome's role as a cornerstone of human health
-
Sylvia Cheung
Biochemist with immunology research experience